Observational studyIn vivo (Athens, Greece)

The Relationship Between Efficacy and Safety of Osimertinib Blood Concentration in Patients With EGFR Mutation-positive Lung Cancer: A Prospective Observational Study.

Yasuhisa Hashino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.